These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25715244)

  • 41. Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema.
    Stolz LE; Sheffer AL
    Expert Rev Clin Immunol; 2012 Jan; 8(1):25-32. PubMed ID: 22149337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.
    Grant JA; White MV; Li HH; Fitts D; Kalfus IN; Uknis ME; Lumry WR
    Allergy Asthma Proc; 2012; 33(4):348-53. PubMed ID: 22856635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial.
    Javaud N; Fain O; Durand-Zaleski I; Launay D; Bouillet L; Gompel A; Sobel A; Woimant M; Rabetrano H; Petrovic T; Lapostolle F; Boccon-Gibod I; Reuter PG; Bertrand P; Mezaour M; Coppere B; Floccard B; Kanny G; Baker E; Martin L; Vicaut E; Adnet F
    Ann Emerg Med; 2018 Aug; 72(2):194-203.e1. PubMed ID: 29503044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies.
    Bonner N; Abetz-Webb L; Renault L; Caballero T; Longhurst H; Maurer M; Christiansen S; Zuraw B;
    Health Qual Life Outcomes; 2015 Jul; 13():92. PubMed ID: 26129930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.
    Bernstein JA; Moellman JJ
    Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current state of hereditary angioedema management: a patient survey.
    Banerji A; Busse P; Christiansen SC; Li H; Lumry W; Davis-Lorton M; Bernstein JA; Frank M; Castaldo A; Long JF; Zuraw BL; Riedl M
    Allergy Asthma Proc; 2015; 36(3):213-7. PubMed ID: 25976438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of hereditary angioedema: a review (CME).
    Bhardwaj N; Craig TJ
    Transfusion; 2014 Nov; 54(11):2989-96; quiz 2988. PubMed ID: 24735226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks.
    Craig TJ; Li HH; Riedl M; Bernstein JA; Lumry WR; MacGinnitie AJ; Stolz LE; Biedenkapp J; Chyung Y
    J Allergy Clin Immunol Pract; 2015; 3(2):206-212.e4. PubMed ID: 25609335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Icatibant for the treatment of hereditary angioedema.
    Cole SW; Lundquist LM
    Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized placebo-controlled trial of the bradykinin Bâ‚‚ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.
    Lumry WR; Li HH; Levy RJ; Potter PC; Farkas H; Moldovan D; Riedl M; Li H; Craig T; Bloom BJ; Reshef A
    Ann Allergy Asthma Immunol; 2011 Dec; 107(6):529-37. PubMed ID: 22123383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
    Craig TJ; Rojavin MA; Machnig T; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2013 Sep; 111(3):211-5. PubMed ID: 23987198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.
    Lumry W; Soteres D; Gower R; Jacobson KW; Li HH; Chen H; Schranz J
    Pediatr Allergy Immunol; 2015 Nov; 26(7):674-80. PubMed ID: 26171584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fresh frozen plasma for the treatment of hereditary angioedema acute attacks.
    Tang R; Chen S; Zhang HY
    Chin Med Sci J; 2012 Jun; 27(2):92-5. PubMed ID: 22770407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of COVID-19 on hereditary angioedema activity and quality of life.
    Can Bostan O; Tuncay G; Damadoglu E; Karakaya G; Kalyoncu AF
    Allergy Asthma Proc; 2021 Sep; 42(5):403-408. PubMed ID: 34474710
    [No Abstract]   [Full Text] [Related]  

  • 55. Ecallantide for the treatment of acute attacks in hereditary angioedema.
    Cicardi M; Levy RJ; McNeil DL; Li HH; Sheffer AL; Campion M; Horn PT; Pullman WE
    N Engl J Med; 2010 Aug; 363(6):523-31. PubMed ID: 20818887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor.
    Schneider L; Lumry W; Vegh A; Williams AH; Schmalbach T
    J Allergy Clin Immunol; 2007 Aug; 120(2):416-22. PubMed ID: 17559913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients.
    Bork K; Bygum A; Hardt J
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):153-61. PubMed ID: 18320917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective study.
    Javaud N; Gompel A; Bouillet L; Boccon-Gibod I; Cantin D; Smaiti N; Carpentier F; Boubaya M; Launay D; Adnet F; Fain O
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):499-503. PubMed ID: 25935434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.
    Bewtra AK; Levy RJ; Jacobson KW; Wasserman RL; Machnig T; Craig TJ
    Allergy Asthma Proc; 2012; 33(5):427-31. PubMed ID: 23026185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema.
    Manson AL; Dempster J; Grigoriadou S; Buckland MS; Longhurst HJ
    Eur J Dermatol; 2014; 24(1):28-34. PubMed ID: 24556385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.